- Vertex Pharmaceuticals (VRTX) is scheduled to announce Q3 earnings results on Monday, November 2, after market close.
- The consensus EPS estimate is $4.75 (-1.0% Y/Y), and the consensus revenue estimate is $3.43B (+11.4% Y/Y).
- Over the last 2 years, VRTX
